Farnesoid X receptor represses hepatic lipase gene expression.

Journal of Lipid Research
Audrey SirventBart Staels

Abstract

The farnesoid X receptor (FXR) is a nuclear receptor that regulates gene expression in response to bile acids (BAs). FXR plays a central role in BA, cholesterol, and lipoprotein metabolism. Here, we identify HL, an enzyme involved in the metabolism of remnant and high density lipoproteins, as a novel FXR-regulated gene. The natural FXR ligand, chenodeoxycholic acid (CDCA), downregulates HL gene expression in a dose- and time-dependent manner in human hepatoma HepG2 cells. The nonsteroidal synthetic FXR agonist GW4064 also decreases HL mRNA levels in HepG2 cells and in primary human hepatocytes. Moreover, the decrease of HL mRNA levels after treatment with FXR agonists was associated with a significant decrease in secreted enzymatic activity. In addition, FXR-specific gene silencing using small interfering RNAs demonstrated that CDCA- and GW4064-mediated downregulation of HL transcript levels occurs via an FXR-dependent mechanism. Finally, using transient transfection experiments, it is shown that FXR represses transcriptional activity of a reporter driven by the -698/+13 bp human HL promoter. Taken together, these results identify HL as a new FXR-regulated gene in human liver cells. In view of the role of HL in plasma lipoprote...Continue Reading

References

Jan 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·P W ConnellyJ A Little
Jan 1, 1987·Differentiation; Research in Biological Diversity·G StahnkeH Will
Nov 1, 1982·Atherosclerosis·W C BreckenridgeG Gardiner
Jan 15, 1997·The Biochemical Journal·B BreedveldH Jansen
Jul 1, 1997·Cell Biology and Toxicology·I J SchippersF Kuipers
May 21, 1999·Science·M MakishimaB Shan
May 21, 1999·Science·D J ParksJ M Lehmann
Aug 24, 2000·Journal of Medicinal Chemistry·P R MaloneyT M Willson
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·J L StaudingerS A Kliewer
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jacqueline R M PlassMichael Müller
Aug 9, 2002·Journal of Medicinal Chemistry·Roberto PellicciariTimothy M Willson
Sep 18, 2002·Journal of Lipid Research·Hans JansenEric J G Sijbrands
Nov 8, 2002·The Journal of Biological Chemistry·Gilles LambertChristopher J Sinal
Aug 2, 2003·Gastroenterology·Thierry ClaudelBart Staels

❮ Previous
Next ❯

Citations

Dec 29, 2010·Current Atherosclerosis Reports·Michael H Davidson
Aug 14, 2013·Journal of Agricultural and Food Chemistry·Huijuan ZhangWallace Yokoyama
Sep 13, 2012·Journal of Biochemistry·Tomofumi FujinoMakio Hayakawa
Feb 8, 2006·Annual Review of Physiology·Nada Y Kalaany, David J Mangelsdorf
Jan 1, 2009·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Ronald B Goldberg
May 11, 2012·Future Medicinal Chemistry·Stefano FiorucciAngela Zampella
Dec 24, 2013·European Journal of Pharmacology·Yuichiro AmanoRyuichi Tozawa
Apr 13, 2010·The Journal of Nutritional Biochemistry·Yuriko Adkins, Darshan S Kelley
Feb 26, 2016·Nature Reviews. Gastroenterology & Hepatology·Mary E Rinella, Arun J Sanyal
Feb 17, 2009·Endocrinology and Metabolism Clinics of North America·Peter P Toth
Dec 28, 2007·Atherosclerosis·William S HarrisErnst J Schaefer
Apr 7, 2007·Trends in Pharmacological Sciences·Bertrand Cariou, Bart Staels
May 26, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jiansheng HuangLi Wang
May 4, 2011·NMR in Biomedicine·Patrícia M NunesRui A Carvalho
Nov 26, 2015·Nutrition & Metabolism·Xianqin ZhangSatoshi Tsuneda
Jul 30, 2005·Ageing Research Reviews·S P MooijaartD van Heemst
Dec 17, 2014·Cellular and Molecular Life Sciences : CMLS·Claire MazuyPhilippe Lefebvre
Jul 11, 2014·PloS One·Clemens RöhrlHerbert Stangl
Oct 18, 2015·Biochemical and Biophysical Research Communications·Liangpeng LiYu Jiang
Jun 19, 2013·Journal of Lipid Research·Cédric LanghiJoan C Rodríguez
Apr 11, 2006·Journal of Lipid Research·Laura E RufibachSamir S Deeb
Jan 8, 2009·Physiological Reviews·Philippe LefebvreBart Staels
Jul 28, 2007·The Biochemical Journal·Takeshi MurakamiBart Staels
Mar 19, 2015·American Journal of Physiology. Endocrinology and Metabolism·Julien PlanchaisJean-Paul Pégorier
Mar 28, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Katrin Panzitt, Martin Wagner

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.